Real World Comparison of Rivaroxaban and Warfarin in Korean Patients with Atrial Fibrillation: Propensity Matching Cohort Analysis

Rivaroxaban has emerged as a potential alternative to warfarin for the prevention of thromboembolism in patients with atrial fibrillation (AF). However, there has been concern for the risk of major bleeding, especially in Asian patients. We investigated the efficacy and safety of rivaroxaban compare...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chonnam Med J
Asıl Yazarlar: Jeong, Hyung Ki, Lee, Ki Hong, Park, Hyung Wook, Yoon, Nam Sik, Kim, Min Chul, Lee, Nuri, Kim, Ji Sung, Ahn, Youngkeun, Jeong, Myung Ho, Park, Jong Chun, Cho, Jeong Gwan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Chonnam National University Medical School 2019
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351319/
https://ncbi.nlm.nih.gov/pubmed/30740341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4068/cmj.2019.55.1.54
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller